SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-000305
Filing Date
2024-01-16
Accepted
2024-01-16 17:16:04
Documents
61
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20231130x10q.htm   iXBRL 10-Q 2057845
2 EX-31.1 cydy-20231130xex31d1.htm EX-31.1 9297
3 EX-31.2 cydy-20231130xex31d2.htm EX-31.2 9438
4 EX-32 cydy-20231130xex32.htm EX-32 7767
  Complete submission text file 0001558370-24-000305.txt   8003431

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20231130.xsd EX-101.SCH 62149
6 EX-101.CAL cydy-20231130_cal.xml EX-101.CAL 48630
7 EX-101.DEF cydy-20231130_def.xml EX-101.DEF 254896
8 EX-101.LAB cydy-20231130_lab.xml EX-101.LAB 419690
9 EX-101.PRE cydy-20231130_pre.xml EX-101.PRE 382341
55 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20231130x10q_htm.xml XML 1391324
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 24535990
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)